[Future aspects of modern Parkinson therapy].
The present limitations of modern antiparkinsonian therapy (decreasing efficacy and increase of side-effects with advancing age and disease duration, lack of causal and neuroprotective therapies) require a multidisciplinary approach in basic, preclinical and clinical research. New substances with higher therapeutic potency and less side-effects, progress in functional stereotaxy, rehabilitation and restorative neurology, and new concepts in neurotransplantation as well as improved knowledge of etiology and pathophysiology are needed for an improvement of therapy.
Ransmayr
G
G
Universittsklinik für Neurologie, Innsbruck.
Jeschow
M
M
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D016380:Brain Tissue Transplantation / Q000502:physiology; D004599:Electric Stimulation Therapy / Q000639:trends; D005544:Forecasting; D006801:Humans; D010300:Parkinson Disease / Q000503:physiopathology / Q000628:therapy*; D010348:Patient Care Team; D013238:Stereotaxic Techniques
D000978:Antiparkinson Agents
Zukunftsaspekte der modernen Parkinson-Therapie.